Alankit Imaginations has entered into a partnership with Digital Swiss Gold (DSG), a digital platform that enables investors to purchase and hold physical gold digitally in Switzerland and also sell and send gold through a mobile app. The partnership will tap into the more than 25 million customer base of Alankit Imaginations’ parent company Alankit, […]
Sonova, a Swiss hearing care solutions provider, has agreed to acquire the consumer electronics division of German audio company Sennheiser electronic for €200m. The Sennheiser consumer division focuses on selling headphones and hearables for private customers. It is said to be an excellent fit with the Swiss firm’s strategy to steer innovation in hearing experience […]
Roivant Sciences has agreed to merge with Montes Archimedes Acquisition (MAAC), a Nasdaq-listed special purpose acquisition company, in a deal that values the Swiss biopharma company at $7.3 billion. Montes Archimedes Acquisition is sponsored by health care investment firm Patient Square Capital. The deal is expected to enable Roivant Sciences to get a listing on […]
Chubb Hartford merger : Swiss property and casualty insurance company Chubb has offered to acquire The Hartford Financial Services Group for $65 per share or $23.24 billion in a cash-cum-stock deal. The Hartford Financial Services Group is a US-based property and casualty insurance company. According to Chubb, the merger of the companies will be strategically […]
VectivBio, a leading Swiss biotechnology firm, has announced the commencement of patient dosing in its phase 3 STARS clinical trial. This trial will evaluate the efficacy and safety of apraglutide, a synthetic glucagon-like peptide-2 (GLP-2) analog, in treating patients with Short Bowel Syndrome (SBS) with intestinal failure (SBS-IF). The STARS trial marks the largest phase […]
Swissmedic, the Swiss Agency for Therapeutic Products, has authorized the use of the BNT162b2 Covid-19 vaccine from US pharma giant Pfizer and German biotech company BioNTech. The Swiss pharma regulator said that as per the data it has assessed, the level of protection afforded seven days following the second dose of the mRNA vaccine is […]
German pharma company Boehringer Ingelheim has signed a deal worth €1.18 billion to acquire NBE-Therapeutics, a clinical-stage Switzerland-based biotech company, focused on developing antibody-drug conjugates (ADCs) and advancing targeted cancer therapies. Through the acquisition, Boehringer Ingelheim will gain access to the Swiss firm’s iADC platform, which is capable of creating immune stimulatory ADCs with an […]
Elliott Advisors (UK) has proposed to take over Swiss food company Aryzta for an indicative price of CHF 0.80 per share. According to Elliott Advisors (UK), the financing for the proposed deal is available and that refinancing arrangements for the existing debt of Aryzta are at a very advanced stage. The investment management company, which […]
NEC acquisition of Avaloq : NEC Corporation, a Japanese IT and electronics company, has agreed to acquire Avaloq Group, a Swiss financial software company, for CHF 2.05 billion ($2.27 billion). Avaloq is a provider of digital banking solutions, core banking software, and wealth management technology. The Swiss fintech company is claimed to have more than […]
Novartis said that a five-year phase 2 clinical trial of migraine prevention drug Aimovig (erenumab-aooe) has delivered strong long-term safety and efficacy results in patients with episodic migraine (EM). The results of the mid-stage trial – NCT01952574 are being presented by the Swiss drugmaker at the 18th Migraine Trust Virtual Symposium. The five-year, open-label treatment […]